Circulation, Stenosis and TAVR - Cardiovascular Update

What Are the Implications of Choosing a TAVR-First Strategy in the Lifetime Management of Aortic Stenosis?: A Critical Review of TAVR-Explant- and Redo-TAVR

Circulation: Cardiovascular Interventions

JANUARY 22, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many.

TAVR

TAVR Aortic valve Aortic Stenosis

Daily Physical Activity Measured by Wearable Smartwatch for Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the SMART TAVR Study

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 13, 2023

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. CONCLUSIONS:Daily step counts rapidly increased within the first 2 months post-TAVR. Increased physical activity was associated with a lower risk of 1-year mortality or rehospitalization after TAVR for patients with daily step counts below 5000.REGISTRATION:URL:[link]

TAVR

TAVR Aortic valve Aortic Outcomes

Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial

Circulation

OCTOBER 25, 2023

Circulation, Ahead of Print. Background:The optimal treatment in patients with severe aortic stenosis (AS) and small aortic annulus (SAA) remains to be determined. There were no differences between groups regarding mortality (TAVR: 1 [1.3%], SAVR: 1 [1.4%], p=1.00) and stroke (TAVR:0, SAVR: 2 [2.7%], p=0.24) at 30 days.

Aortic valve

Aortic valve Aortic TAVR Stenosis

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients.

Aortic valve

Aortic valve Aortic TAVR Heart Valves

Abstract 4142104: Ischemic Stroke and TIA Incidence in Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement: A Comparative Systematic Review and Meta-analysis

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142104-A4142104, November 12, 2024. Seven studies showed that TAVR patients had a similar 1-year stroke risk to SAVR patients (OR 0.92, 95% CI 0.64 Heterogeneity was assessed using I2 statistics. All statistical analyses were conducted using Review Manager (Rev Man, Version 5.4;

Aortic valve

Aortic valve Aortic TAVR Stroke

Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation

Circulation

OCTOBER 23, 2023

Circulation, Ahead of Print. Background: Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) and is associated with increased risk of bleeding and stroke. Patients were randomized 1:1 to TAVR+LAAO or TAVR+medical therapy. For the composite primary endpoint, TAVR+.LAAO

Aortic valve

Aortic valve Atrial Fibrillation TAVR Aortic

Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights from the STS/ACC TVT Registry

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Exposure of interest was PVD. Primary outcome was all-cause mortality.

Aortic valve

Aortic valve Aortic TAVR Outcomes

Diffuse Subendocardial Ischemia on the ECG. Left main? 3-vessel disease? No!

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

A transthoracic echocardiogram showed an LV EF of less than 15%, critically severe aortic stenosis , severe LVH , and a small LV cavity. The aortic valve in this example also had critical stenosis by Doppler The patient continued to be hemodynamically unstable with poor cardiac output and very high LV filling pressures.

Ischemia

Ischemia Cardiogenic Shock Aortic Stenosis

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. Aortic stenosis.

TAVR

TAVR Stenosis Aortic Aortic valve

Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis

Circulation: Cardiovascular Interventions

MARCH 26, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Current guidelines recommend surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and unfavorable iliofemoral access. At 30 days, the SAVR group showed a higher rate of the primary composite outcome compared with the TC-TAVR group (12.6%

Aortic valve

Aortic valve Aortic Stenosis TAVR

Extracellular Matrix Proteins Improve Risk Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundCardiac fibrosis is common in patients with severe aortic stenosis and an independent predictor of death. ConclusionsCirculating TIMP1 is an independent predictor of reduced 2year overall survival in patients undergoing TAVR. 95% CI, 2.69.7];P<0.001) P<0.001) and multivariable (adjusted hazard ratio, 2.2 [95%

Aortic valve

Aortic valve Aortic TAVR Biomarkers

Associations of Sarcopenia and Body Composition Measures With Mortality After Transcatheter Aortic Valve Replacement

Circulation: Cardiovascular Interventions

JANUARY 18, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Frailty associates with worse outcomes after transcatheter aortic valve replacement (TAVR). Among the 3 components of sarcopenia, only slower gait speed (muscle performance) was independently associated with increased post-TAVR mortality (adjusted hazard ratio, 1.12

Aortic valve

Aortic valve Aortic TAVR Stenosis

Highlights of ACC 2024

Cardiology Update

APRIL 9, 2024

SMART 4 ( NCT04722250 ) studied patients with severe aortic stenosis and a small aortic annulus who underwent transcatheter aortic valve replacement (TAVR). A total of 716 patients underwent TAVR with either a self-expanding supraannular valve or a balloon-expandable valve. It is able to deliver 3.5L/min

Angina

Angina Myocardial Infarction Aortic valve Coronary Artery Disease

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

What Are the Implications of Choosing a TAVR-First Strategy in the Lifetime Management of Aortic Stenosis?: A Critical Review of TAVR-Explant- and Redo-TAVR

Daily Physical Activity Measured by Wearable Smartwatch for Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the SMART TAVR Study

Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial

Webinars

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Abstract 4142104: Ischemic Stroke and TIA Incidence in Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement: A Comparative Systematic Review and Meta-analysis

Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation

Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights from the STS/ACC TVT Registry

Diffuse Subendocardial Ischemia on the ECG. Left main? 3-vessel disease? No!

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis

Extracellular Matrix Proteins Improve Risk Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement

Associations of Sarcopenia and Body Composition Measures With Mortality After Transcatheter Aortic Valve Replacement

Highlights of ACC 2024

Published Research

Published Research

Stay Connected